Title21 Software announces a partnership with iNTERFACEWARE to provide robust data interfacing capabilities between Title21 Software and Health Level Seven (HL7) enabled information systems.
Title21 Software, Inc, (“Title21”) a provider of innovative electronic solutions for laboratories and other Hospital systems, announces their strategic partnership with iNTERFACEWARE, a technology leader in delivering HL7 integration. Title21 Software now interfaces with industry standard HL7 enabled information systems, integrating disparate data sources into one complete solution.
This collaboration leverages iNTERFACEWARE’s expertise in providing powerful HL7 interfaces with Title21Software’s highly configurable and expansive technology. Title21’s platform now has the capability to integrate data from existing and future hospital systems including HIEs, EMRs, LIS, CIS, CRDB, PACs, HIS, RIS utilizing any standard including HL7 (v2 and v3), CDA, XML, X12, DICOM, eRX, Flat file and Web Services.
“Our primary focus in healthcare is to provide completely integrated solutions to achieve greater efficiencies, and improve quality and compliance in labs and hospitals resulting in a higher level of patient care,” said Lynn Fischer, CEO of Title21 Software. “We are thrilled to now be able to deliver and delight our customers using iNTERFACEWARE’s robust and seamless integration technologies that will improve the lab’s overall work and productivity.”
The capability for Title21 customers to interface with their existing HL7 information systems directly from Title21 will heighten the quality and integrity of data, as well as save time and eliminate redundant data entry.
“Title21 Software is an innovative industry leader with very unique technology. We are pleased to begin this partnership and offer Title21’s customers the powerful solutions of IGUANA, by iNTERFACEWARE,” stated Eliot Muir, CEO of iNTERFACEWARE. “Title21 and iNTERFACEWARE solutions are an ideal combination to simplify integration and streamline laboratory processes, which is a mission we both share.”
